Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Novel thrombolytic agents

M Verstraete1, H R Lijnen

  • 1Center for Molecular and Vascular Biology, University of Leuven, Belgium.

Cardiovascular Drugs and Therapy
|December 1, 1994
PubMed
Summary

The fibrinolytic system regulates blood clot breakdown. Genetic studies in mice show that altering key components significantly impacts thrombolysis, highlighting targets for improved clot-busting drugs.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Platelet rescue by macrophage depletion in obese ADAMTS-13-deficient mice at risk of thrombotic thrombocytopenic purpura.

Journal of thrombosis and haemostasis : JTH·2017
Same author

Reproducibility of studies with genetically modified mice.

Journal of thrombosis and haemostasis : JTH·2017
Same author

Macrophage elastase (MMP-12) in expanding murine adipose tissue.

Biochimica et biophysica acta·2013
Same author

The hyperfibrinolytic state of mice with combined thrombin-activatable fibrinolysis inhibitor (TAFI) and plasminogen activator inhibitor-1 gene deficiency is critically dependent on TAFI deficiency.

Journal of thrombosis and haemostasis : JTH·2012
Same author

Unveiling an exceptional zymogen: the single-chain form of tPA is a selective activator of NMDA receptor-dependent signaling and neurotoxicity.

Cell death and differentiation·2012
Same author

Effect of ageing on the murine venous circulation.

Histochemistry and cell biology·2012

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Genetics

Background:

  • The fibrinolytic system dissolves blood clots by converting plasminogen to plasmin.
  • Tissue-type plasminogen activator (t-PA) and urokinase-type plasminogen activator (u-PA) are key activators.
  • Dysregulation of fibrinolysis is linked to bleeding and thrombosis.

Purpose of the Study:

  • To investigate the in vivo role of fibrinolytic components in thrombosis and thrombolysis using transgenic animal models.
  • To explore the limitations of current thrombolytic agents and identify avenues for improvement.

Main Methods:

  • Homologous recombination was used to inactivate specific genes in mice.
  • Transgenic animal models were employed to study thrombosis and thrombolysis.
  • Analysis of thrombolytic activity and spontaneous lysis rates.

Main Results:

  • Inactivation of tissue-type plasminogen activator (t-PA) genes significantly impaired thrombolysis in mice.
  • Inactivation of plasminogen activator-1 gene accelerated spontaneous clot lysis.
  • Current thrombolytic agents have limitations like resistance to reperfusion and bleeding complications.

Conclusions:

  • Genetic manipulation of fibrinolytic components profoundly affects thrombolysis in vivo.
  • There is a continued need for novel thrombolytic agents with enhanced potency, specificity, and fibrin-selectivity.
  • Future research directions include developing modified plasminogen activators and exploring agents from diverse origins.

Related Experiment Videos